Brief: Initiator Pharma - Positive Results From Pudafensine Phase I Pharmacokinetic Trial
July 18 (Reuters) - Initiator Pharma A/S INIT.ST :
* ANNOUNCES POSITIVE RESULTS FROM PUDAFENSINE PHASE I
PHARMACOKINETIC TRIAL
* REPORTED ADVERSE EVENTS WERE OF MILD SEVERITY AND ONLY
POTENTIALLY RELATED TO TREATMENT
Source text for Eikon: ID:nMFN3yJV0p
Further company coverage: INIT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Initiator Pharma A/S
See all newsBrief: Initiator Pharma Q1 2026 Operating Loss DKK 11.4 Mln
Brief: Initiator Pharma To Fully Prioritize Pudafensine
Brief: Initiator Pharma Reports Q4 Net Revenue Of DKK 0.00
Brief: Initiator Pharma Q4 Operating Loss Widens To DKK 7 Mln
Brief: Initiator Pharma Granted European Patent For Pudafensine in FSD